Another study evaluated oxLDL in 54 late-onset AD patients (aged 77 years, 81% female, MMSE score = 18) and 51 healthy elderly individuals (aged 77 years, 73% male, MMSE score = 29) and a relationship between oxLDL and PON1-107C/T polymorphism and the APOE genotype [87]. The gene discussed is PON1; the disease is Alzheimer disease.